abstract |
Preparation for oral administration of a macrolide compound, characterized in that the elution of the macrolide compound is sustained, preferably a solid dispersion or a macrolide compound in which the macrolide compound is present in an amorphous state in a solid base. A sustained release formulation containing fine powder as a component is provided. |